Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#104 / 160 Total
LICN - Lichen China Ltd - Stock Price Chart
TickerLICN [NASD]
CompanyLichen China Ltd
CountryChina
IndustrySpecialty Business Services
Market Cap28.08MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-78.21%
P/S-EPS next 5Y-
P/B-EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own51.56%Inst Own0.00%
Insider Trans0.00%Inst Trans-
Short Float0.49%Earnings-
Analyst Recom-Target Price-
Avg Volume966.40K52W Range0.50 - 2.84
Lichen China Ltd. engages in providing financial and taxation solutions. It also offers educational support, and software and maintenance services. The company was founded by Li Ya on April 13, 2016 and is headquartered in Jinjiang, China.
NKGN - NKGen Biotech Inc - Stock Price Chart
TickerNKGN [NASD]
CompanyNKGen Biotech Inc
CountryUSA
IndustryBiotechnology
Market Cap30.14MEPS (ttm)-4.10
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-989.64%
Dividend-Sales Q/Q-
Insider Own60.46%Inst Own14.37%
Insider Trans0.01%Inst Trans14.32%
Short Float4.77%Earnings-
Analyst Recom-Target Price-
Avg Volume3.58M52W Range0.78 - 12.88
Apr-29-24 08:00AM NKGen Biotech Announces FDA Clearance of Investigational New Drug (IND) Application for SNK01 NK Cell Therapy in Parkinsons Disease (GlobeNewswire)
Apr-25-24 04:05PM NKGen Biotech Presents Updated NK Cell Therapy Data for Neurodegenerative Disease at the 12th Annual Alzheimer's & Parkinson's Drug Development Summit (GlobeNewswire) +15.79%
Apr-24-24 04:45PM NKGen Biotech Announces Upcoming Publication at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting (GlobeNewswire) -7.57%
Apr-18-24 04:05PM NKGen Biotech Announces Upcoming Presentation on SNK01 NK Cell Therapy in Neurodegenerative Disease at the 12th Annual Alzheimer's & Parkinson's Drug Development Summit (GlobeNewswire) -16.50%
Apr-16-24 11:53PM NKGN Stock Earnings: NKGen Biotech Reported Results for Q4 2023 (InvestorPlace)
Apr-11-24 08:05AM NKGen Biotech Secures Additional Financing of $5 Million to Continue Advancing Its Clinical Programs (GlobeNewswire)
Mar-25-24 04:05PM NKGen Biotech Presents Additional Phase 1 Clinical Trial Data in Alzheimer's Disease at the Tau2024 Global Conference (GlobeNewswire) -6.90%
Mar-06-24 07:52AM Why Is NKGen Biotech (NKGN) Stock Up 62% Today? (InvestorPlace) +112.30%
Mar-04-24 08:00AM NKGen Biotech Announces Upcoming Presentation on SNK01 in Alzheimer's Disease at the Tau2024 Global Conference (GlobeNewswire)
Feb-07-24 08:57AM Passage of the Amendment to the Advanced Regenerative Biotech Act a Positive Catalyst for Korean and Japanese Cell Therapy Companies (News Direct)
NKGen Biotech, Inc. is a clinical-stage biotechnology company, which focuses on the development and commercialization of innovative autologous, allogeneic, and CAR-NK cell therapies utilizing a proprietary SNK platform. Its product candidates are based on a proprietary manufacturing and cryopreservation process which produces SNK cells that have high potency as defined by parameters such as cytotoxicity, cytokine production, and activating receptor expression. The company was founded by Sangwoo Park in 2017 and is headquartered in Santa Ana, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Song Paul Y.Chief Executive OfficerDec 07 '23Buy3.2976250171,121Dec 07 05:23 PM
Song Paul Y.Chief Executive OfficerDec 06 '23Buy3.3275250171,045Dec 07 05:23 PM
Song Paul Y.Chief Executive OfficerDec 05 '23Buy3.33105350170,969Dec 05 03:51 PM
Graf James AInterim CFODec 04 '23Buy3.194501,436693Dec 05 03:50 PM
Song Paul Y.Chief Executive OfficerDec 04 '23Buy3.07163500170,864Dec 05 03:51 PM
LVTX - LAVA Therapeutics NV - Stock Price Chart
TickerLVTX [NASD]
CompanyLAVA Therapeutics NV
CountryNetherlands
IndustryBiotechnology
Market Cap74.66MEPS (ttm)-1.59
P/E-EPS this Y4.94%
Forward P/E-EPS next Y-37.86%
PEG-EPS past 5Y86.55%
P/S11.03EPS next 5Y-
P/B1.46EPS Q/Q57.45%
Dividend-Sales Q/Q-86.63%
Insider Own46.29%Inst Own15.12%
Insider Trans0.00%Inst Trans-2.70%
Short Float1.37%EarningsMar 20/b
Analyst Recom1.00Target Price7.25
Avg Volume1.09M52W Range1.13 - 6.47
LAVA Therapeutics NV is an immuno-oncology company, which engages in the proprietary Gammabody platform to develop a portfolio of bispecific gamma delta T cell engagers for the potential treatment of solid tumors and hematological malignancies. The company was founded by Erik van den Berg in 2016 and is headquartered in Utrecht, the Netherlands.
SYNX - Silynxcom Ltd - Stock Price Chart
TickerSYNX [AMEX]
CompanySilynxcom Ltd
CountryUSA
IndustryCommunication Equipment
Market Cap-EPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own-Inst Own-
Insider Trans-Inst Trans-
Short Float-Earnings-
Analyst Recom1.00Target Price8.00
Avg Volume11.89K52W Range2.67 - 4.10
PRTS - CarParts.com Inc - Stock Price Chart
TickerPRTS [NASD, RUT]
CompanyCarParts.com Inc
CountryUSA
IndustryInternet Retail
Market Cap67.97MEPS (ttm)-0.15
P/E-EPS this Y-140.00%
Forward P/E-EPS next Y30.56%
PEG-EPS past 5Y-0.12%
P/S0.10EPS next 5Y15.00%
P/B0.57EPS Q/Q5.11%
Dividend-Sales Q/Q1.21%
Insider Own8.82%Inst Own74.68%
Insider Trans0.00%Inst Trans-0.53%
Short Float5.34%EarningsMay 07/a
Analyst Recom1.00Target Price4.00
Avg Volume742.08K52W Range1.19 - 5.16
CarParts.com, Inc. operates as an online provider of aftermarket auto parts and accessories in the United States and the Philippines. Its products include Collision Parts, Engine Parts, Performance Parts and Accessories. The firm also sells auto parts to collision repair shops, markets Kool-Vue products to auto parts wholesale distributor, and aftermarket catalytic converters under the Evan Fischer brand. Its flagship Websites include www.carparts.com, www.jcwhitney.com, www.autopartswarehouse.com and www.usautoparts.com. The company was founded by Sol Khazani and Mehran Nia in 1995 and is headquartered in Carson, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Meniane DavidChief Executive OfficerApr 18 '24Option Exercise0.0067,26101,515,850Apr 22 04:21 PM
Lockwood RyanChief Financial OfficerApr 18 '24Option Exercise0.0022,254091,109Apr 22 04:24 PM
Subramanian KalsChief Technology OfficerApr 18 '24Option Exercise0.0016,786061,994Apr 22 04:28 PM
Subramanian KalsChief Technology OfficerFeb 06 '24Option Exercise0.0024,482053,594Feb 08 04:34 PM
Lockwood RyanChief Financial OfficerFeb 06 '24Option Exercise0.0021,527077,677Feb 08 04:28 PM
SMHI - SEACOR Marine Holdings Inc - Stock Price Chart
TickerSMHI [NYSE, RUT]
CompanySEACOR Marine Holdings Inc
CountryUSA
IndustryMarine Shipping
Market Cap323.20MEPS (ttm)-0.84
P/E-EPS this Y-217.65%
Forward P/E-EPS next Y30.56%
PEG-EPS past 5Y37.85%
P/S1.14EPS next 5Y-
P/B0.93EPS Q/Q-136.00%
Dividend-Sales Q/Q4.66%
Insider Own17.96%Inst Own44.43%
Insider Trans0.00%Inst Trans-1.63%
Short Float0.84%EarningsMay 01/a
Analyst Recom1.00Target Price17.00
Avg Volume203.67K52W Range7.51 - 15.24
SEACOR Marine Holdings, Inc. engages in the provision of offshore marine business. It offers global marine and support transportation services to offshore oil & gas exploration, development, and production facilities. It operates through the following geographic segments: United States (primarily in the Gulf of Mexico), Africa and Europe, Middle East and Asia, and Latin America. The company was founded on December 15, 2014, and is headquartered in Houston, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Persily JulieDirectorNov 03 '23Sale13.4520,000269,00067,852Nov 06 05:10 PM
Regan Robert ChristopherDirectorNov 03 '23Sale13.3220,000266,40046,874Nov 06 05:09 PM
Llorca JesusEVP & CFOOct 20 '23Sale15.181,98730,163376,297Oct 23 04:34 PM
Everett Andrew H IISr. VP, General Counsel & SecyOct 20 '23Sale15.181,64725,001196,178Oct 23 04:35 PM
Llorca JesusEVP & CFOOct 19 '23Sale15.0911,138168,072378,284Oct 23 04:34 PM
CHRO - Chromocell Therapeutics Corp. - Stock Price Chart
TickerCHRO [AMEX]
CompanyChromocell Therapeutics Corp.
CountryUSA
IndustryBiotechnology
Market Cap9.58MEPS (ttm)-1.27
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-436.04%
Dividend-Sales Q/Q-
Insider Own70.67%Inst Own8.28%
Insider Trans0.00%Inst Trans-
Short Float0.06%Earnings-
Analyst Recom-Target Price-
Avg Volume31.38K52W Range1.21 - 6.00
Chromocell Therapeutics Corp. is a clinical-stage biotech company that engages in the development and commercialization of new therapeutics to alleviate pain. Its clinical focus is to selectively target the sodium ion-channel known as NaV1.7, as well as other receptors in the NaV family. The company was founded on March 19, 2021 and is headquartered in Freehold, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Davis Todd CDirectorFeb 21 '24Option Exercise4.8029,167140,00229,167Feb 23 05:15 PM
Friedberg Ezra MDirectorFeb 21 '24Option Exercise4.8020,64199,077520,719Feb 23 05:12 PM
SPRU - Spruce Power Holding Corporation - Stock Price Chart
TickerSPRU [NYSE]
CompanySpruce Power Holding Corporation
CountryUSA
IndustrySolar
Market Cap78.16MEPS (ttm)-2.67
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.97EPS next 5Y-
P/B0.37EPS Q/Q-434.67%
Dividend-Sales Q/Q-8.90%
Insider Own19.58%Inst Own17.65%
Insider Trans0.00%Inst Trans-53.34%
Short Float2.65%EarningsMay 15/a
Analyst Recom3.00Target Price48.00
Avg Volume51.46K52W Range3.09 - 8.40
Spruce Power Holding Corp. engages in the ownership and operation of distributed solar energy assets. The firm provides subscription-based services for homeowners and small businesses to own and maintain rooftop solar and battery storage. It offers products relating to battery solutions, system expansion, extended service agreement, and fleet management. The company was founded by Thomas J. Hynes, III in 2009 and is headquartered in Denver, CO.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LEDECKY JONATHAN JDirectorJun 07 '23Buy0.8039,68931,854363,710Jun 08 10:59 AM
LEDECKY JONATHAN JDirectorJun 06 '23Buy0.8410,0258,421324,021Jun 07 06:26 PM
LEDECKY JONATHAN JDirectorJun 05 '23Buy0.811,192966313,996Jun 07 06:26 PM
Tech Eric M.DirectorJun 01 '23Buy0.8110,0008,100891,444Jun 05 03:42 PM
Tech Eric M.DirectorJun 01 '23Buy0.8110,0008,10025,000Jun 05 03:42 PM
IFRX - InflaRx N.V. - Stock Price Chart
TickerIFRX [NASD]
CompanyInflaRx N.V.
CountryGermany
IndustryBiotechnology
Market Cap76.25MEPS (ttm)-0.85
P/E-EPS this Y-18.72%
Forward P/E-EPS next Y5.99%
PEG-EPS past 5Y9.74%
P/S1089.28EPS next 5Y-
P/B0.67EPS Q/Q-57.16%
Dividend-Sales Q/Q-
Insider Own17.08%Inst Own29.26%
Insider Trans0.00%Inst Trans-18.47%
Short Float0.26%EarningsMay 08/b
Analyst Recom1.40Target Price8.01
Avg Volume233.18K52W Range1.14 - 5.20
InflaRx NV is a clinical-stage biopharmaceutical company, which engages in the discovery and development of inhibitors of the complement activation factor known as C5a and its receptor C5aR. Its primary product candidate is Vilobelimab. The company was founded by Niels Christoph Riedemann, Renfeng Guo, and Nicolas Fulpius in December 2007 and is headquartered in Jena, Germany.
DWSN - Dawson Geophysical Company - Stock Price Chart
TickerDWSN [NASD]
CompanyDawson Geophysical Company
CountryUSA
IndustryOil & Gas Equipment & Services
Market Cap42.52MEPS (ttm)-0.46
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y15.68%
P/S0.44EPS next 5Y41.80%
P/B1.35EPS Q/Q41.47%
Dividend0.00%Sales Q/Q65.45%
Insider Own0.00%Inst Own87.74%
Insider Trans-Inst Trans0.12%
Short Float0.02%EarningsNov 09/b
Analyst Recom2.00Target Price4.00
Avg Volume21.69K52W Range1.08 - 2.26
Dawson Geophysical Co. engages in the provision of onshore seismic data acquisition services. The firm is also involved in acquiring and processing 2-D, 3-D, and multi-component seismic data to providers of multi-client data libraries for use in the onshore drilling and production of oil and natural gas as well as directly to onshore oil and natural gas exploration and development companies. The company was founded by L. Decker Dawson in 1952 and is headquartered in Midland, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Wilks Brothers, LLC10% OwnerJun 14 '23Buy2.238,89519,83618,847,330Jun 16 08:08 PM
Wilks Brothers, LLC10% OwnerJun 13 '23Buy2.194,4389,71917,650,200Jun 14 06:16 PM
Wilks Brothers, LLC10% OwnerJun 12 '23Buy2.174,1669,04017,645,762Jun 14 06:16 PM
1678910111213141516